BMS-741672

DB19004InvestigationalSmall molecule

BMS-741672 is under investigation in clinical trial NCT00699790 (Proof of Confidence Study of CCR2 Antagonist (BMS-741672) in Insulin Resistance).

Mechanism: Pharmacologically active on C-C chemokine receptor type 2
Curator reviewed
Formula / weight: C₂₄H₃₃F₃N₆O₃S · 542.62 g/mol (avg)
Also known as: N-(5-(ISOPROPYL(METHYL)AMINO)-2-(2-OXO-3-((6-(TRIFLUOROMETHYL)QUINAZOLIN-4-YL)AMINO)PYRROLIDIN-1-YL)CYCLOHEXYL)METHANESULFONAMIDE
Code names: BMS-741672

Resolves to

Compound

Structure

InChIKeyPJTGSIKANITYOO-RCOXNQKVSA-NSMILESCC(C)N(C)[C@@H]1CC[C@@H]([C@@H](C1)NS(C)(=O)=O)N1CC[C@H](NC2=NC=NC3=CC=C(C=C23)C(F)(F)F)C1=O

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with BMS-741672, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.